secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-09-10T10:00:47+00:00
Accession:  0001156039-26-000063
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance reaffirms FY2026 EPS guidance: at least $20.10 GAAP, $27.00 adjusted
-----------------------------------------------------------------------------

- Reaffirms FY2026 shareholders' EPS guidance of at least $20.10, including ~$6.90 net unfavorable items.
- Excluding items, adjusted shareholders' EPS guidance at least $27.00 per diluted share.
- Reaffirms FY2026 benefit expense ratio guidance of 90.2% ± 50 basis points.
- Guidance reaffirmed during investor meetings over the next several weeks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000063/0001156039-26-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000063/elv-20260910.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer